Organic and Biomolecular Chemistry p. 4794 - 4803 (2016)
Update date:2022-08-05
Topics:
Jacques, Sylvain A.
Leriche, Geoffray
Mosser, Michel
Nothisen, Marc
Muller, Christian D.
Remy, Jean-Serge
Wagner, Alain
pH-Sensitive linkers designed to undergo selective hydrolysis at acidic pH compared to physiological pH can be used for the selective release of therapeutics at their site of action. In this paper, the hydrolytic cleavage of a wide variety of molecular structures that have been reported for their use in pH-sensitive delivery systems was examined. A wide variety of hydrolytic stability profiles were found among the panel of tested chemical functionalities. Even within a structural family, a slight modification of the substitution pattern has an unsuspected outcome on the hydrolysis stability. This work led us to establish a first classification of these groups based on their reactivities at pH 5.5 and their relative hydrolysis at pH 5.5 vs. pH 7.4. From this classification, four representative chemical functions were selected and studied in-vitro. The results revealed that only the most reactive functions underwent significant lysosomal cleavage, according to flow cytometry measurements. These last results question the acid-based mechanism of action of known drug release systems and advocate for the importance of an in-depth structure-reactivity study, using a tailored methodology, for the rational design and development of bio-responsive linkers.
View MoreLuoyang Aoda chemical Co.,Ltd.
Contact:+86-379-67518785 67516588
Address:MiaoWan industry district,YanShi City,Henan,China
Valiant Fine Chemicals Co., Ltd.
Contact:+86 535 6101878/6374484
Address:11 Wuzhishan Rd.,YTETDZ,Yantai,264006,Shandong,China
Contact:+33-5-34012600
Address:28 ZA des Pignès
Qingdao XinYongAn Chemicals Co., Ltd
Contact:+86-532-81107967
Address:Chengyang dual-port industrial park by the sea,Qingdao
Feis International Trade Co,. Ltd
Contact:13961823444-18235944442
Address:Wuxi jiangsu
Doi:10.1016/j.ejmech.2013.01.056
(2013)Doi:10.1021/jo000630j
(2000)Doi:10.1021/acsmedchemlett.0c00387
(2020)Doi:10.1021/jo062457i
(2007)Doi:10.1002/ejic.201500054
(2015)Doi:10.1016/S0040-4039(01)80247-1
(1984)